Cargando…

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma

N6-methyladenosine (m6A) is the most common type of RNA methylation and is considered to participate in various biological and pathological processes, specifically in the regulation of tumorigenesis and metastasis. However, the exact prognostic role of m6A methylation regulators in early-stage clear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhan, Zhang, Mingxin, Seery, Samuel, Zheng, Guoyang, Wang, Wenda, Zhao, Yang, Wang, Xu, Zhang, Yushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214704/ https://www.ncbi.nlm.nih.gov/pubmed/35761938 http://dx.doi.org/10.3892/ol.2022.13370

Ejemplares similares

Development and validation of prognostic nomogram for elderly patients with clear cell renal cell carcinoma based on the SEER database
por: Lin, Mingxin, et al.
Publicado: (2023)

Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

High-throughput screening of circRNAs reveals novel mechanisms of tuberous sclerosis complex-related renal angiomyolipoma
por: Zhao, Yang, et al.
Publicado: (2021)

Solitary vaginal paraganglioma with mature sacrococcygeal teratoma: a rare case report
por: Wang, Zhan, et al.
Publicado: (2021)

Correction: Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes: A case report
por: Zheng, Guoyang, et al.
Publicado: (2017)

Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Liu, Chen, et al.
Publicado: (2022)

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinoma
por: Deng, Qiong, et al.
Publicado: (2023)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
por: Ma, Xuzhan, et al.
Publicado: (2023)

Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma
por: Han, Wenkai, et al.
Publicado: (2020)

Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes
por: Qian, Cheng, et al.
Publicado: (2023)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model
por: liu, Xiaoyan, et al.
Publicado: (2023)

Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte‐associated genes
por: Chen, Can, et al.
Publicado: (2022)

Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020)

Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
por: Tang, Yanlin, et al.
Publicado: (2023)

Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis
por: Li, Yiling, et al.
Publicado: (2022)

Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma
por: Zhou, Qi, et al.
Publicado: (2021)

Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2020)

High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC
por: Wang, Zhan, et al.
Publicado: (2020)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2022)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Identification of Differentially Methylated Genes Associated with Clear Cell Renal Cell Carcinoma and Their Prognostic Values
por: Wan, Bin, et al.
Publicado: (2023)

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma
por: Chen, Guang, et al.
Publicado: (2016)

Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes
por: Nie, Shiwen, et al.
Publicado: (2022)

Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma
por: Shi, Zhiyuan, et al.
Publicado: (2022)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

Prognostic Inflammasome-Related Signature Construction in Kidney Renal Clear Cell Carcinoma Based on a Pan-Cancer Landscape
por: Zheng, Tianyu, et al.
Publicado: (2020)

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2019)

Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Prognostic, clinicopathological, and immune correlation of NLRP3 promoter methylation in kidney renal clear cell carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Construction and validation of a novel ten miRNA-pair based signature for the prognosis of clear cell renal cell carcinoma
por: Wang, Yulin, et al.
Publicado: (2022)

Discovery and construction of prognostic model for clear cell renal cell carcinoma based on single-cell and bulk transcriptome analysis
por: Zhang, Fangyuan, et al.
Publicado: (2021)

Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma
por: Long, Qian, et al.
Publicado: (2021)

Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma
por: Ren, Shiqi, et al.
Publicado: (2020)

Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
por: Wang, Jiawei, et al.
Publicado: (2023)

Expression of CIDE proteins in clear cell renal cell carcinoma and their prognostic significance
por: Yu, Ming, et al.
Publicado: (2013)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bh92qcqhc3matugbs1v4r5i3l1